20114 ⎘
Medicinal preparations characterised by special physical form; Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Progesterone containing oral dosage forms and kits
#902Particulate comprising a calcium-containing compound and a sugar alcohol
#903Tamper-resistant tablet providing immediate drug release
#904Method for improving dissolution of anticoagulant agent
#905Controlled release and taste masking oral pharmaceutical composition
#906Controlled release pharmaceutical compositions of tapentadol
#907Controlled Release Formulations of Opioids
#908Tamper Resistant Dosage Form Comprising an Adsorbent and an Adverse Agent
#909MODIFIED RELEASE FORMULATIONS OF MEMANTINE ORAL DOSAGE FORMS
#910CONTROLLED RELEASE NANOPARTICULATE COMPOSITIONS
#911Solid Pharmaceutical Dosage Formulation
#912SUSTAINED-RELEASE SOLID PREPARATION FOR ORAL USE
#913SOLID DISPERSIONS CONTAINING 20-O-beta-D-GLUCOPYRANOSYL-20(S)-PROTOPANAXADIOL
#914TABLETED COMPOSITIONS CONTAINING ATAZANAVIR
#915TECHNOLOGY FOR PREVENTING ABUSE OF SOLID DOSAGE FORMS
#916Controlled Release and Taste Masking Oral Pharmaceutical Composition
#917Controlled release and taste making oral pharmaceutical composition
#918Pharmaceutical Compositions Having Improved Dissolution Profiles For Poorly Soluble Drugs
#919Orodispersible tablet containing compacted sildenafil base
#920Oral Preparation Having Improved Quality
#921DIRECT COMPRESSION FORMULATION AND PROCESS
#922DRUG CARRIER WITH THERMAL SENSITIVITY, MANUFACTURING METHOD THEREOF, AND USE THEREOF
#923Pharmaceutical compositions comprising colloidal silicon dioxide
#924Opioid agonist formulations with releasable and sequestered antagonist
#925Tamper-resistant oral opioid agonist formulations
#926RAPIDLY DISPERSING GRANULES, ORALLY DISINTEGRATING TABLETS AND METHODS
#927TASTE MASKED PHARMACEUTICAL FORMULATIONS
#928Pharmaceutical composition for treating parkinson's disease and preparation method thereof
#929MELT-GRANULATED CINACALCET
#930Eutectic-based self-nanoemulsified drug delivery system
#931Process for Preparing Pramipexole Dihydrochloride Tablets
#932Dual drug dosage forms with improved separation of drugs
#933Controlled release hydrocodone formulations
#934PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN, PROCESSES FOR THEIR OBTAINMENT AND METHOD OF TREATING INTESTINAL DISEASE
#935ABUSE-RESISTANT OPIOID DOSAGE FORM
#936SUSTAINED RELEASE CANNABINOID MEDICAMENTS
#937ABUSE-RESISTANT OPIOID DOSAGE FORM
#938CHOLINE FENOFIBRATE DELAYED RELEASE COMPOSITIONS
#939Controlled Release and Taste Masking Oral Pharmaceutical Composition
#940Modified release formulation of lacosamide
#941DPP IV INHIBITOR FORMULATIONS
#942PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
#943Solid pharmaceutical compositions containing an integrase inhibitor
#944Controlled release and taste masking oral pharmaceutical composition
#945Moisture Resistant Container Systems for Rapidly Bioavailable Dosage Forms
#946PHARMACEUTICAL COMPOSITIONS WITH TETRABENAZINE
#947Dosage forms for tamper prone therapeutic agents
#948Solid pharmaceutical dosage form
#949DRUG FORMULATIONS
#950Pharmaceutical formulation containing an opioid agonist, opioid antagonist and irritant agent
#951DEFERACIROX DISPERSIBLE TABLETS
#952Controlled-release melatonin compositions and related methods
#953ORAL DOSAGE FORM FOR MODIFIED RELEASE COMPRISING A JAK3 INHIBITOR
#954PHARMACEUTICAL FORMULATIONS CONTAINING MICROPARTICLES OR NANOPARTICLES OF A DELIVERY AGENT
#955Matrix for sustained, invariant and independent release of active compounds
#956Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials
#957Extended release formulation of an antiepileptic agent
#958Use of a copolymer in the form of a solubiliser for a poorly water-soluble compound
#959Oral dosage formulation containing both immediate-release and sustained-release drugs for treating neurodegenerative disorders
#960Controlled release formulations of levodopa and uses thereof
#961Diffusion-controlled dosage form and method of fabrication including three dimensional printing
#962COMPOSITIONS COMPRISING AND METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2
#963Threo-DOPS controlled release formulation
#964RAPIDLY DISINTEGRATING SOLID PREPARATION
#965Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application
#966PHARMACEUTICAL FORMULATIONS
#967Pharmaceutical formulations to prevent the misuse of medicinal drugs
#968Granulating process and thus prepared granulate
#969Encased tamper resistant controlled release dosage forms
#970Delayed release formulation for reducing the frequency of urination and method of use thereof
#971NICOTINIC ACID COMPOSITIONS FOR TREATING HYPERLIPIDEMIA AND RELATED METHODS THEREFOR
#972ANTACID AND LAXATIVE TABLET
#973Prasugrel in non-crystalline form and pharmaceutical composition thereof
#974BITTER TASTE MASKING DOSAGE FORM
#975ALCOHOL RESISTANT DOSAGE FORMS
#976Modified release tranexamic acid formulation
#977Tamper resistant dosage form comprising a matrix and melt-extruded particulates comprising a drug
#978TABLET
#979Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein
#980Sustained-release composition containing tetrahydropyrido[4,3-b]indole derivatives and preparation of the derivatives
#981ATAZANAVIR FORMULATIONS
#982PHARMACEUTICAL FORMULATIONS COMPRISING VALGANCICLOVIR
#983Ferric citrate dosage forms
#984RAPIDLY DISINTEGRATING SOLID ORAL DOSAGE FORM
#985Tanaproget compositions containing ethinyl estradiol
#986PHARMACEUTICAL PREPARATION CONTAINING OXYCODONE AND NALOXONE
#987PHARMACEUTICAL COMPOSITIONS CONTAINING A COMBINATION OF AN ANTIHISTAMINE AND A DECONGESTANT
#988Sustained-Release Tablet and Process for Preparing the Same
#989ORALLY DISINTEGRATING TABLETS COMPRISING DIPHENHYDRAMINE
#9903′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
#991TASTE-MASKED ORAL FORMULATIONS OF INFLUENZA ANTIVIRALS
#992PHARMACEUTICAL COMPOSITIONS OF ACTIVE PHARMACEUTICAL INGREDIENT COMPRISING SULPHONYLUREA MOIETY WITH EXCELLENT DISSOLUTION PROPERTIES
#993REDUCTION OF OPIOID BLOOD FLUCTUATIONS
#994Process for making compositions with poorly compressible therapeutic compounds
#995Pharmaceutical compositions of ranolazine
#996Oral formulations and lipophilic salts of methylnaltrexone
#997Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use
#998NOVEL NIMESULIDE COMPOSITIONS
#999Therapeutic or prophylactic agent for dyskinesia
#1000SOLID RETIGABINE IN NON-CRYSTALLINE FORM
#1001Liquid ganaxolone formulations and methods for the making and use thereof
#1002PHARMACEUTICAL COMPOSITIONS OF (R)-1-(2,2-DIFLUOROBENZO[D] [1,3]DIOXOL-5-YL)-N-(1-(2,3-DIHYDROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2-YL)-1H-INDOL-5-YL) CYCLOPROPANECARBOXAMIDE AND ADMINISTRATION THEREOF
#1003INTERMEDIATE AND ORAL ADMINISTRATIVE FORMATS CONTAINING LENALIDOMIDE
#1004Resveratrol compositions
#1005Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
#1006Extended Release Pharmaceutical Preparations for Active Pharmaceutical Ingredients with pH Dependent Solubility
#1007Sustained release aminopyridine composition
#1008Pharmaceutical compositions comprising Brivaracetam
#1009TABLET FORMULATION FOR P38 INHIBITOR AND METHOD
#1010Tablet and pestle therefor
#1011Tacrolimus for improved treatment of transplant patients
#1012Process for preparation of anti-tubercular combination and pharmaceutical composition prepared therefrom
#1013PHARMACEUTICAL COMPOSITION CONTAINING A "LIMUS" FAMILY IMMUNOSUPPRESSIVE MACROLIDE
#1014Stable pharmaceutical composition for atherosclerosis
#1015Solid pharmaceutical dosage form
#1016AMORPHOUS AMBRISENTAN
#1017CONTROLLED RELEASE AND TASTE-MASKING ORAL PHARMACEUTICAL COMPOSITION
#1018Controlled release and taste masking oral pharmaceutical composition
#1019Modified release formulations containing drug-ion exchange resin complexes
#1020PALATABLE PHARMACEUTICAL COMPOSITION
#1021TABLET FORMULATION
#1022Pharmaceutical composition for treatment of type 2 diabetes
#1023COMPACTED CINACALCET
#1024MODIFIED RELEASE FORMULATIONS OF MEMANTINE ORAL DOSAGE FORMS
#1025DPP IV INHIBITOR FORMULATIONS
#1026Pharmaceutical composition of nanoparticles for protein drug delivery
#1027DEFERACIROX DISPERSIBLE TABLETS
#1028Progesterone Containing Oral Dosage Forms and Related Methods
#1029Progesterone Containing Oral Dosage Forms and Related Methods
#1030Solid dispersions containing kinase inhibitors
#1031PHARMACEUTICAL COMPOSITIONS COMPRISING COLLOIDAL SILICON DIOXIDE
#1032Process for making particles for delivery of drug nanoparticles
#1033Method
#1034METHODS AND SUSTAINED RELEASE NICOTINIC ACID COMPOSITIONS FOR TREATING HYPERLIPIDEMIA
#1035PHARMACEUTICAL COMPOSITIONS COMPRISING 5-CHLORO-N-(-METHYL)-2-THIOPHENCARBOXAMID
#1036CONTROLLED RELEASE NANOPARTICULATE CLOZAPINE COMPOSITIONS
#1037Pharmaceutical Formulation Comprising Metformin and Repaglinide
#1038Fast Dissolving Tablet
#1039And potent tapentadol dosage forms
#1040Tacrolimus For Improved Treatment Of Transplant Patients
#1041Modified release pharmaceutical compositions of dexlansoprazole
#1042Solid dispersions comprising tacrolimus
#1043Controlled release hydrocodone formulations
#1044PRECOMPACTED FAST-DISINTEGRATING FORMULATIONS OF COMPOUNDS WITH A LOW ORAL BIOAVAILABILITY
#1045RAPID-ACTING PHARMACEUTICAL COMPOSITION
#1046Opioid agonist formulations with releasable and sequestered antagonist
#1047Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof
#1048Modified release compositions comprising tacrolimus
#1049Solid pharmaceutical composition comprising amlodipine and losartan
#1050Modified release compositions comprising tacrolimus
#1051Modified release compositions comprising tacrolimus
#1052Modified release compositions comprising tacrolimus
#1053Highly efficient and long-acting slow-release formulation of poorly soluble drugs and preparation method thereof
#1054Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same
#1055Solid pharmaceutical composition comprising amlodipine and losartan with improved stability
#1056NICOTINIC ACID COMPOSITIONS FOR TREATING HYPERLIPIDEMIA AND RELATED METHODS THEREFOR
#1057NICOTINIC ACID COMPOSITIONS FOR TREATING HYPERLIPIDEMIA AND RELATED METHODS THEREFOR
#1058Controlled release of N-acetylcysteine (NAC) for reduction of systemic and/or vascular inflammation
#1059Mesoporous material excipients for poorly aqueous soluble ingredients
#1060PHARMACEUTICAL FORMULATIONS
#1061Solid ganaxolone formulations and methods for the making and use thereof
#1062DIRECT COMPRESSION FORMULATION AND PROCESS
#1063GRANULAR PHARMACEUTICAL COMPOSITIONS
#1064Dosage forms that facilitate rapid activation of barley protease zymogen
#1065Extended release compositions comprising mycophenolate sodium and processes thereof
#1066PHARMACEUTICAL FORMULATIONS CONTAINING IRBESARTAN
#1067DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
#1068Octreotide implant having a release agent
#1069MODAFINIL FORMULATIONS
#1070Stabilized tacrolimus composition
#1071Pharmaceutical Dosage Form of an Antidepressant
#1072CHRONOTHERAPEUTIC PHARMACEUTICAL DOSAGE FORM
#1073Sustained Release Pharmaceutical Composition Containing Metformin Hydrochloride
#1074CONTROLLED RELEASE COMPOSITIONS OF ROPINIROLE
#1075Pharmaceutical preparation containing gabapentin
#1076ORAL DOSAGE FORMS HAVING A HIGH LOADING OF A TRANEXAMIC ACID PRODRUG
#1077Pharmaceutical formulation
#1078Multi-unit gastroretentive pharmaceutical dosage form comprising microparticles
#1079In-Vivo Non-Viral Gene Delivery of Human Vascular Endothelial Growth Factor Following Islet Transplantation
#1080PHARMACEUTICAL DOSAGE FORM COMPRISING POLYMERIC CARRIER COMPOSITION
#1081MULTIPARTICULATE TABLET AND METHOD FOR THE PRODUCTION THEREOF
#1082PH-SENSITIVE SOLID PHARMACEUTICAL COMPOSITION FOR ORAL PREPARATION AND PREPARATION METHOD THEREOF
#1083Method for treating neurodegenerative disorders with oral dosage formulation containing both immediate-release and sustained-release drugs
#1084METHOD AND PREPARATION FOR BINDING ACETALDEHYDE IN SALIVA, THE STOMACH AND THE LARGE INTESTINE
#1085SUSTAINED RELEASE MONOEXIMIC FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS
#1086PHARMACEUTICAL COMPOSITION FOR USE IN TREATING SEXUALLY TRANSMITTED INFECTIONS
#1087Galenical formulations of organic compounds
#1088Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
#1089IBUPROFEN AND NARCOTIC ANALGESIC COMPOSITIONS
#1090Pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof
#1091ANDROGRAPHIS EXTRACT FORMULATIONS
#1092Controlled Release Dosage Form of Tacrolimus
#1093Rapid dissolution formulation of a calcium receptor-active compound
#1094SINGLE DOSAGE PHARMACEUTICAL FORMULATION COMPRISING EPROSARTAN MESYLATE
#1095ABUSE-RESISTANT OPIOID DOSAGE FORM
#1096Ondansetron Orally Disintegrating Tablet Compositions for Prevention of Nausea and Vomiting
#1097PHARMACEUTICAL COMPOSITIONS CONTAINING PREGABALIN
#1098PHARMACEUTICAL PREPARATION CONTAINING NON-DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-2 RECEPTOR BLOCKER
#1099EXTENDED RELEASE COMPOSITIONS CONTAINING TOLTERODINE AND PROCESS FOR PREPARING THE SAME
#1100Analgetic dosage forms that are resistant to parenteral and inhalation dosing and have reduced side effects
#1101TABLET COMPRISING EPROSARTAN MESYLATE
#1102Immediate release formulations and dosage forms of gamma-hydroxybutyrate
#1103High Drug Load Formulations and Dosage Forms
#1104Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use
#1105Coated tablet formulations and uses thereof
#1106Moisture resistant container systems for rapidly bioavailable dosage forms
#1107Process for production of spherical microparticles comprising tamsulosin hydrochloride
#1108Pharmaceutical compositions of antiretrovirals
#1109Tamper-resistant oral opioid agonist formulations
#1110MELT GRANULATION PROCESS
#1111Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability
#1112Pharmaceutical compositions comprising brivaracetam
#1113Anti-misuse solid oral pharmaceutical form provided with a specific modified release profile
#1114DELAYED RELEASE COMPOSITIONS
#1115NOVEL DOSAGE FORMULATION
#1116Extended release dosage forms of metoprolol
#1117Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
#1118EXTENDED RELEASE FORMULATION OF LEVETIRACETAM
#1119EXTENDED RELEASE FORMULATION OF LEVETIRACETAM
#1120PHARMACEUTICAL COMPOSITION CONTAINING ACETYLCHOLINE ESTERASE INHIBITOR AND METHOD FOR THE PREPARATION THEREOF
#1121MODIFIED RELEASE LAMOTRIGINE TABLETS
#1122PHARMACEUTICAL COMPOSITION
#1123PHARMACEUTICAL PREPARATION FOR TREATING CARDIOVASCULAR DISEASE
#1124Orally Disintegrting Forms for Sustained Release and Controlled Release
#1125DEFERACIROX DISPERSIBLE TABLETS
#1126SOLID PHARMACEUTICAL COMPOSITION COMPRISING IRBESARTAN
#1127Prolonged release bioadhesive therapeutic systems
#1128PHARMACEUTICAL COMPOSITION WITH ATORVASTATIN ACTIVE INGREDIENT
#1129COMPOSITE PREPARATION
#1130Controlled release hydrocodone formulations
#1131SOLID DOSAGE FORMS OF HIV PROTEASE INHIBITORS
#1132GALENICAL FORMULATIONS OF ORGANIC COMPOUNDS
#1133VALSARTAN SOLID ORAL DOSAGE FORMS AND METHODS OF MAKING SUCH FORMULATIONS
#1134SEQUESTERING SUBUNIT AND RELATED COMPOSITIONS AND METHODS
#1135Nanoparticulate statin formulations and novel statin combinations
#1136CONTROLLED RELEASE FORMULATIONS
#1137Lanthanum composition
#1138Solid dispersion and pharmaceutical composition of the same, and production processes thereof
#1139ABUSE-RESISTANT OPIOID DOSAGE FORM
#1140USE OF 5-AMINOLEVULINIC ACID AND DERIVATIVES IN A SOLID FORM FOR PHOTODYNAMIC TREATMENT AND DIAGNOSIS
#1141Solid pharmaceutical dosage form
#1142Solid preparation comprising alogliptin and metformin hydrochloride
#1143Sequestering subunit and related compositions and methods
#1144Solid pharmaceutical dosage form
#1145Anti-retroviral combination
#1146NICOTINIC ACID COMPOSITIONS FOR TREATING HYPERLIPIDEMIA AND RELATED METHODS THEREFOR
#1147SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS
#1148SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS
#1149SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS
#1150PHARMACEUTICAL COMPOSITIONS HAVING IMPROVED DISSOLUTION PROFILES FOR POORLY SOLUBLE DRUGS
#1151Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient
#1152FORMULATION AND PROCESS FOR DRUG LOADED CORES
#1153PHARMACEUTICAL COMPOSITION
#1154Sequestering subunit and related compositions and methods
#1155PHARMACEUTICAL FORMULATIONS
#1156Orally disintegrating tablet compositions of lamotrigine
#1157Controlled release formulations of levodopa and uses thereof
#1158MULTIPLE UNIT PHARMACEUTICAL FORMULATION
#1159FORMULATION FOR ORAL ADMINISTRATION OF APOPTOSIS PROMOTER
#1160Method to stabilize a dietary supplement to facilitate joint health in humans
#1161Compositions of phytosterols with enhanced bioavailability
#1162GRANULES, TABLETS AND METHOD OF PRODUCING THE SAME
#1163Orally administrable solid pharmaceutical composition and a process thereof
#1164TABLETS FOR COMBINATION THERAPY
#1165Multiparticulate Extended Release Pharmaceutical Composition Of Carbamazepine And Process For Manufacturing The Same
#1166Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
#1167PROCESS FOR FORMING SOLID ORAL DOSAGE FORMS OF ANGIOTENSIN II RECEPTOR ANTAGONISTS
#1168Orally disintegrating tablets with speckled appearance
#1169Composition Comprising Desmopressin
#1170SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION
#1171SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION
#1172SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION
#1173PHARMACEUTICAL COMPOSITION OF MEMANTINE
#1174Powder and its method of manufacture
#1175Pharmaceutical compositions of fenofibrate
#1176Controlled release matrix pharmaceutical dosage formulation
#1177Pharmaceutical Compositions and Methods of Using Same
#1178Compressed chewing gum tablet
#1179Process for Preparing Pramipexole Dihydrochloride Tablets
#1180SUSTAINED RELEASE TABLETS WITH HYDROMORPHONE
#1181COMPOSITION AND METHOD OF TREATING A SORE THROAT
#1182Combinations of statins and anti-obesity agent
#1183Composition for foodstuff for binding acetaldehyde
#1184Misuse preventative, controlled release formulation
#1185Combinations of statins and anti-obesity agent
#1186RAPIDLY DISINTEGRATING SOLID PREPARATION
#1187DOSAGE FORMS COMPRISING CELECOXIB PROVIDING BOTH RAPID AND SUSTAINED PAIN RELIEF
#1188Pharmaceutical Composition Comprising Amlodipine and Losartan
#1189LOW DOSE SUBLINGUAL TABLETS OF OPIOID ANALGESICS AND PREPARATION PROCESS
#1190Taste Masked Phamaceutical Composition for Oral Solid Dosage form and Process for Preparing the Same Using Magnesium Aluminium Silicate
#1191Rate-Controlled Oral Dosage Formulations
#1192Composition and method of treating a sore throat
#1193Pellets Comprising a Core With a Water-Soluble Carrier
#1194PHARMACEUTICAL COMPOSITIONS COMPRISING COLLOIDAL SILICON DIOXIDE
#1195Method of treating a sore throat
#1196PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF
#1197Bitter Taste Masking Dosage Form
#1198Pharmaceutical compositions comprising intra-and extra-granular fractions
#1199SYNERGISTIC ANTIBACTERIAL FORMULATION AND A METHOD OF MAKING THE SAME
#1200Process of making crystalline type II aripiprazole